
News|Articles|March 1, 2024
An ophthalmologist with personal experience has explored the impact of AI-driven solutions
Advertisement
Advertorial: An ophthalmologist with personal experience has explored the impact of AI-driven solutions
Dr. Alberto Piatti, the chief ophthalmologist of the diabetic center at the A.S.L T05 health district in Turin, Italy has been actively engaged in diabetic retinopathy (DR) screenings for decades. In 2019, the health center implemented an integrated DR care pathway between diabetologists and ophthalmologists. The aim was to introduce advancements such as telemedicine and utilizing arti icial intelligence. According to Dr. Piatti, technological improvements and especially AI have radically transformed DR screening.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Eye Care Network - Ophthalmology Times
1
FLORetina-ICOOR 2026: AI moves from the image to the trial, the clinic, and the operating room
2
Water-soluble CBD eye drops lower IOP and dampen corneal sensitivity in glaucoma mouse model
3
BL1332 misses primary end point in phase 2 post-PRK ocular pain study
4
Q&A: GLP-1 RAs and NAION, the case for a baseline exam
5










